Valion Bio, Inc. (VBIO) Operating margin 2021–2024
Valion Bio, Inc. (VBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-573.8%FY2024 · since FY2021: -448.1% → -573.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -573.8% | +127.3 pp |
| FY2023 | -701.1% | -152.3 pp |
| FY2022 | -548.8% | -100.7 pp |
| FY2021 | -448.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VBIO financial trends
VBIO RevenueVBIO Net incomeVBIO Net marginVBIO Gross profitVBIO Gross marginVBIO Operating incomeVBIO Operating cash flowVBIO Free cash flowVBIO Capital expendituresVBIO Return on equityVBIO Stock buybacksVBIO Dividends paidVBIO Total assetsVBIO Total liabilitiesVBIO Shareholders’ equityVBIO overview →